| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |